Teva gets US FDA nod to market generic Prevacid delayed-release capsules
Friday, November 13, 2009 10:00 IST Jerusalem, Israel
Teva Pharmaceutical Industries Ltd. announced that the US Food and Drug Administration has granted final approval for the company's Abbreviated New Drug Application (ANDA) to market